Treatment of macular edema in vascular retinal diseases: a 2021 update
A Grzybowski, A Markeviciute, R Zemaitiene - Journal of clinical medicine, 2021 - mdpi.com
Macular edema (ME) is associated with various conditions; however, the main causes of ME
are retinal vein occlusion (RVO) and diabetes. Laser photocoagulation, formerly the gold …
are retinal vein occlusion (RVO) and diabetes. Laser photocoagulation, formerly the gold …
The correlation between cytokine levels in the aqueous humor and the prognostic value of anti-vascular endothelial growth factor therapy for treating macular edema …
H Yong, H Qi, H Yan, Q Wu, L Zuo - Graefe's Archive for Clinical and …, 2021 - Springer
Purpose To determine the correlation between aqueous humor cytokine levels and the
prognostic value of anti-vascular endothelial growth factor (VEGF) therapy for treating …
prognostic value of anti-vascular endothelial growth factor (VEGF) therapy for treating …
Wide-field swept-source OCT angiography of the periarterial capillary-free zone before and after anti-VEGF therapy for branch retinal vein occlusion
W Tang, W Liu, J Guo, L Zhang, G Xu, K Wang… - Eye and Vision, 2022 - Springer
Background The aim of the study was to investigate the changes in the periarterial capillary-
free zone (paCFZ) after anti-vascular endothelial growth factor (VEGF) therapy in patients …
free zone (paCFZ) after anti-vascular endothelial growth factor (VEGF) therapy in patients …
The anti-inflammatory and anti-oxidative effects of conbercept in treatment of macular edema secondary to retinal vein occlusion
JP Xia, S Wang, JS Zhang - Biochemical and biophysical research …, 2019 - Elsevier
To investigate the effects of conbercept on inflammatory and oxidative response in macular
edema secondary to retinal vein occlusion (RVO-ME). Retinal microvasculature were …
edema secondary to retinal vein occlusion (RVO-ME). Retinal microvasculature were …
Clinical implications of retinal oximetry in retinal vein occlusion: a review
AV Belamkar, S Jabbehdari, A Harris… - Acta …, 2022 - Wiley Online Library
Purpose To review retinal vein occlusion (RVO) and its relationship with retinal oxygen
saturation via automated retinal oximetry in eyes with RVO. Methods A literature review was …
saturation via automated retinal oximetry in eyes with RVO. Methods A literature review was …
[PDF][PDF] 玻璃体腔注射康柏西普联合激光治疗视网膜静脉阻塞黄斑水肿的长期疗效
赵中芳， 杜改萍 - 中华眼视光学与视觉科学杂志, 2020 - cjoovs.com
摘要目的: 观察玻璃体腔内注射康柏西普联合激光治疗视网膜静脉阻塞(RVO)
继发黄斑水肿(ME) 的长期疗效. 方法: 前瞻性系列病例研究. 纳入2016 年1 月31 日至2017 年1 …
继发黄斑水肿(ME) 的长期疗效. 方法: 前瞻性系列病例研究. 纳入2016 年1 月31 日至2017 年1 …
Impact and implication of fovea-involving intraretinal hemorrhage after acute branch retinal vein occlusion
JH Powers, AS Thomas, TA Mir, JS Kim… - Ophthalmology …, 2019 - Elsevier
Purpose To compare clinical outcomes in patients with branch retinal vein occlusion (BRVO)
with (group A) or without (group B) fovea-involving intraretinal hemorrhage (IRH). Design …
with (group A) or without (group B) fovea-involving intraretinal hemorrhage (IRH). Design …
[HTML][HTML] Comparative efficacy of intravitreal pharmacotherapy for macular edema secondary to retinal vein occlusion: A protocol for the systematic review and network …
Y Zhang, J Duan, T Chang, X Li, M Wang, M Zhang - Medicine, 2020 - journals.lww.com
Background: Multiple intravitreal pharmacotherapies including different anti-vascular
endothelial growth factors (VEGF), intravitreal steroids, and combined therapy with anti …
endothelial growth factors (VEGF), intravitreal steroids, and combined therapy with anti …
[PDF][PDF] RANIBIZUMAB V LÉČBĚ MAKULÁRNÍHO EDÉMU PŘI VĚTVOVÉ SÍTNICOVÉ ŽILNÍ OKLUZI–DVOULETÉ VÝSLEDKY LÉČBY
MUDM Středová - scholar.archive.org
SOUHRN Cíl: Retrospektivní zhodnocení výsledků léčby makulárního edému (ME) na
podkladě větvové sítnicové žilní okluze (BRVO) intravitreálně podávaným ranibizumabem v …
podkladě větvové sítnicové žilní okluze (BRVO) intravitreálně podávaným ranibizumabem v …
Trombosis de la vena central de la retina (TVCR) bilateral asociada a síndrome de hiperviscosidad en una Macroglobulinemia de Waldenströ m (MW)-a propósito de …
VTL López, CFM López, FHG Monsalve… - ARS MEDICA Revista …, 2019 - arsmedica.cl
Introducción: la Macroglobulinemia de Waldenströ m (MW) es un tipo raro de linfoma de
células B caracterizado por la proliferación de células linfoplasmocíticas que secretan altas …
células B caracterizado por la proliferación de células linfoplasmocíticas que secretan altas …